Should You Buy the Post-Earnings Dip in Bath & Body Works Stock?

Core Viewpoint - Bath & Body Works (BBWI) shares experienced a significant decline of nearly 25% following disappointing Q3 financial results and a negative revenue forecast for Q4, despite being a holiday season staple [1][2] Financial Performance - The stock is down over 60% from its year-to-date high in late February [2] - Expected free cash flow for the year is approximately $650 million, with plans for $400 million in share buybacks [6] Strategic Initiatives - The new CEO, Daniel Heaf, is implementing a transformation plan called the "Consumer First Formula," targeting $250 million in cost savings over the next two years [3][4] - The strategy includes exiting non-core segments, launching on Amazon to capture an estimated $70 million in gray market sales, and reducing organizational complexity [4] Valuation and Investment Potential - BBWI shares are currently trading at about 6x forward earnings, which is considered attractive given the company's cash flow generation [5] - Wall Street maintains a consensus rating of "Moderate Buy" for BBWI, with a mean target price of around $35, indicating a potential upside of approximately 130% [8]